Evonile Pharma Limited (NSE:EVONILE)
India · Delayed Price · Currency is INR 1,865.20
+46.20 (2.54%)
At close: Nov 9, 2026
Evonile Pharma Market Cap
Evonile Pharma has a market cap or net worth of 45.96 billion as of November 10, 2026. Its market cap has increased by 123.90% in one year.
Market Cap
45.96B
Enterprise Value
50.90B
Revenue
3.36B
Global Rank
n/a
Country Rank
n/a
PE Ratio
n/a
ChartMarket Cap Chart
Since April 14, 1999, Evonile Pharma's market cap has increased from 12.59B to 45.96B, an increase of 265.20%. That is a compound annual growth rate of 4.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 9, 2026 | 45.96B | 138.96% |
| Dec 31, 2025 | 19.23B | -15.31% |
| Dec 31, 2024 | 22.71B | 18.95% |
| Dec 29, 2023 | 19.09B | 14.56% |
| Dec 30, 2022 | 16.67B | -12.94% |
| Dec 31, 2021 | 19.14B | 13.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Strides Pharma Science | 92.18B |
| Aarti Pharmalabs | 83.70B |
| Sun Pharma Advanced Research Company | 68.41B |
| Innova Captab | 61.23B |
| Orchid Pharma | 52.94B |
| RPG Life Sciences | 42.95B |
| Solara Active Pharma Sciences | 31.31B |
| Ind-Swift Laboratories | 30.52B |